NCT05686044: A trial that was reported late by Annovis Bio Inc.
This trial has reported, although it was 4 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT05686044 |
|---|---|
| Title | A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study of Buntanetap in Participants With Mild to Moderate Alzheimer's Disease |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 1, 2023 |
| Completion date | Feb. 13, 2024 |
| Required reporting date | Feb. 12, 2025, midnight |
| Actual reporting date | Feb. 17, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 4 |